1-15 of 15
Pinuccia Valagussa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LBO1-02: Pathologic complete response (pCR) of neoadjuvant therapy with or without atezolizumab in HER2-positive, early high-risk and locally advanced breast cancer: APTneo Michelangelo randomized trial

Luca Gianni, Elisabetta Munzone, Mauro Mansutti, Giampaolo Bianchini, Yann Izarzuzaga, Elena Rota Caremoli, Luc Dirix, Lucia Del Mastro, Santiago González-Santiago, Andreas Schneeweiss, Jose Ponce, Chiun-Shen Huang, Pauline Wimberger, Sevilay Altintas, Miguel Martín, Nicoleta Antone, Christian F. Singer, Ugo De Giorgi, Ana Godoy Ortiz, Hans-Joachim Lueck, Riccardo Spezia, Angelica Fasolo, Giuseppe Viale, Pinuccia Valagussa
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): LBO1-02.
https://doi.org/10.1158/1538-7445.SABCS23-LBO1-02
Published: 02 May 2024
View article titled, Abstract LBO1-02: Pathologic complete response (pCR) of neoadjuvant therapy with or without atezolizumab in HER2-positive, early high-risk and locally advanced breast cancer: APTneo Michelangelo randomized trial
Journal Articles

Abstract PD10-09: Comparison of early modulation of biological pathways and immune microenvironment by anthracyclines- or taxane-based treatment

Maurizio Callari, Marco Barreca, Matteo Dugo, Barbara Galbardi, Lucia Viganò, Alberta Locatelli, Luca Licata, Giulia Viale, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD10-09.
https://doi.org/10.1158/1538-7445.SABCS21-PD10-09
Published: 15 February 2022
View article titled, Abstract PD10-09: Comparison of early modulation of biological pathways and immune microenvironment by anthracyclines- or taxane-based treatment
Journal Articles

Abstract PD10-06: Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Robert S. Seitz, Tyler J. Nielsen, Marc Thill, Antonio Anton, Stefania Russo, Eva Maria Ciruelos, Brock L. Schweitzer, Douglas T. Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Balázs Gyorffy, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Pinuccia Valagussa, Giuseppe Viale, Maurizio Callari, Luca Gianni, Giampaolo Bianchini
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD10-06.
https://doi.org/10.1158/1538-7445.SABCS21-PD10-06
Published: 15 February 2022
View article titled, Abstract PD10-06: Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial
Journal Articles

Abstract GS1-00: Single-cell spatial analysis by imaging mass cytometry and immunotherapy response in triple-negative breast cancer (TNBC) in the NeoTRIPaPDL1 trial

Giampaolo Bianchini, Xiao Qian Wang, Esther Danenberg, Chiun-Sheng Huang, Daniel Egle, Maurizio Callari, Begoña Bermejo, Claudio Zamagni, Marc Thill, Anton Anton, Matteo Dugo, Stefania Zambelli, Stefania Russo, Eva Maria Ciruelos, Richard Greil, Vladimir Semiglazov, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Balázs Győrffy, Olivia Biasi, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, H Raza Ali
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): GS1-00.
https://doi.org/10.1158/1538-7445.SABCS21-GS1-00
Published: 15 February 2022
View article titled, Abstract GS1-00: Single-cell spatial analysis by imaging mass cytometry and immunotherapy response in triple-negative breast cancer (TNBC) in the NeoTRIPaPDL1 trial
Journal Articles

Abstract P1-04-02: Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial

Maurizio Callari, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Matteo Dugo, Marc Thill, Antonio Anton, Marco Barreca, Stefania Russo, Eva Maria Ciruelos, Richard Greil, Stefania Zambelli, Balázs Gyorffy, Chanel Smart, Olivia Biasi, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-04-02.
https://doi.org/10.1158/1538-7445.SABCS21-P1-04-02
Published: 15 February 2022
View article titled, Abstract P1-04-02: Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial
Journal Articles

Abstract P2-07-12: Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Robert S. Seitz, Tyler J. Nielsen, Marc Thill, Antonio Anton, Stefania Russo, Eva Maria Ciruelos, Brock L. Schweitzer, Douglas T. Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Balázs Gyorffy, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Pinuccia Valagussa, Giuseppe Viale, Maurizio Callari, Luca Gianni, Giampaolo Bianchini
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-07-12.
https://doi.org/10.1158/1538-7445.SABCS21-P2-07-12
Published: 15 February 2022
View article titled, Abstract P2-07-12: Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial
Journal Articles

Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study

Luca Gianni, Chiun-Sheng Huang, Daniel Egle, Begona Bermejo, Claudio Zamagni, Marc Thill, Antonio Anton, Stefania Zambelli, Giampaolo Bianchini, Stefania Russo, Eva Ciruelos, Richrad Greil, Vladimir Semiglazov, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Ilaria Maffeis, Pinuccia Valagussa, Giuseppe Viale
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): GS3-04.
https://doi.org/10.1158/1538-7445.SABCS19-GS3-04
Published: 15 February 2020
View article titled, Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
Journal Articles

Abstract P5-06-21: Prognostic and predictive value of PML in the ETNA study and the TCGA

Stefania Zambelli, Chanel Smart, Giampaolo Bianchini, Isabella Sassi, Mauro Mansutti, Antonio Anton, Lourdes Calvo, Giancarlo Bisagni, Begona Bermejo, Martina Uggè, Barbara Galbardi, Vladimir Semiglazov, Marc Thill, Jose Ignacio Chacon, Arlene Chan, Serafin Morales Murillo, Isabel Alvarez, Ainhara Lahuerta, Patrizia Zucchinelli, Claudio Doglioni, Pinuccia Valagussa, Ignasi Tusquets, Luca Gianni, Rosa Bernardi
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-06-21.
https://doi.org/10.1158/1538-7445.SABCS19-P5-06-21
Published: 15 February 2020
View article titled, Abstract P5-06-21: Prognostic and predictive value of PML in the ETNA study and the TCGA
Journal Articles

Abstract PD5-05: Clinical implication of tumor infiltrating lymphocytes (TILs) in the ETNA study

Giampaolo Bianchini, Chanel Smart, Mauro Mansutti, Antonio Anton, Luca Licata, Isabella Sassi, Lourdes Calvo, Giancarlo Bisagni, Begona Bermejo, Vladimir Semiglazov, Marc Thill, Jose Ignacio Chacon, Arlene Chan, Serafin Morales Murillo, Isabel Alvarez, Ainhara Lahuerta, Patrizia Zucchinelli, Claudio Doglioni, Giuseppe Viale, Pinuccia Valagussa, Ignasi Tusquet, Luca Gianni
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD5-05.
https://doi.org/10.1158/1538-7445.SABCS19-PD5-05
Published: 15 February 2020
View article titled, Abstract PD5-05: Clinical implication of tumor infiltrating lymphocytes (TILs) in the ETNA study
Journal Articles

Abstract P5-06-02: Pathologic complete response (pCR) and prognosis following neoadjuvant chemotherapy plus anti-HER2 therapy of HER2-positive early breast cancer (EBC)

Sibylle Loibl, Michael Untch, Marc Buyse, André Robidoux, Luca Gianni, Andreas Schneeweiss, Pierfranco Conte, Martine Piccart, Hervé Bonnefoi, Christian Jackisch, Valentina Nekljudova, Joseph Costantino, Pinuccia Valagussa, Colin Neate, Richard Gelber, Coralie Poncet, Pierre Squifflet, Everardo Saad, Dominik Heinzmann, Carsten Denkert, Charles E Geyer, Jr., Javier Cortes, Valentina Guarneri, Evandro de Azambuja, David Cameron, Gustavo Ismael, Gunter von Minckwitz, Norman Wolmark, Patricia Cortazar
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-06-02.
https://doi.org/10.1158/1538-7445.SABCS19-P5-06-02
Published: 15 February 2020
View article titled, Abstract P5-06-02: Pathologic complete response (pCR) and prognosis following neoadjuvant chemotherapy plus anti-HER2 therapy of HER2-positive early breast cancer (EBC)
Journal Articles

Abstract P1-18-01: Risk of recurrence and death in patients with early HER2-positive breast cancer who achieve a pathological complete response (pCR) after different types of HER2-targeted therapy: A retrospective exploratory analysis

Sandra M Swain, Harrison Macharia, Javier Cortes, Chau Dang, Luca Gianni, Sara Hurvitz, Christian Jackisch, Andreas Schneeweiss, Dennis Slamon, Pinuccia Valagussa, Yolande du Toit, Dominik Heinzmann, Adam Knott, Chunyan Song, Patricia Cortazar
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P1-18-01.
https://doi.org/10.1158/1538-7445.SABCS19-P1-18-01
Published: 15 February 2020
View article titled, Abstract P1-18-01: Risk of recurrence and death in patients with early HER2-positive breast cancer who achieve a pathological complete response (pCR) after different types of HER2-targeted therapy: A retrospective exploratory analysis
Journal Articles

Abstract P4-14-01: Modulation of tumor infiltrating lymphocytes (TILs) by palbociclib, trastuzumab, pertuzumab +/- fulvestrant in ER+/HER2+ patients (pts) enrolled in the Michelangelo NA-PHER2 trial

Giampaolo Bianchini, Chanel Smart, Giancarlo Bisagni, Marco Colleoni, Mauro Mansutti, Claudio Zamagni, Lucia Del Mastro, Stefania Zambelli, Luca Licata, Antonio Frassoldati, Giuseppe Viale, Pinuccia Valagussa, Luca Gianni
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P4-14-01.
https://doi.org/10.1158/1538-7445.SABCS19-P4-14-01
Published: 15 February 2020
View article titled, Abstract P4-14-01: Modulation of tumor infiltrating lymphocytes (TILs) by palbociclib, trastuzumab, pertuzumab +/- fulvestrant in ER+/HER2+ patients (pts) enrolled in the Michelangelo NA-PHER2 trial
Journal Articles

Abstract 3940: Baseline molecular markers and risk of distant relapse in the NeoSphere study

Giampaolo Bianchini, Tadeusz Pienkowski, Young-Hyuck Im, Giulia Valeria Bianchi, Ling-Ming Tseng, Mei-Ching Liu, Ana Lluch, Vladimir Semiglazov, Juan de la Haba-Rodríguez, Do-Youn Oh, Brigitte Poirier, Jose Luiz Pedrini, Pinuccia Valagussa, Luca Gianni
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3940.
https://doi.org/10.1158/1538-7445.AM2016-3940
Published: 15 July 2016
View article titled, Abstract 3940: Baseline molecular markers and risk of distant relapse in the NeoSphere study
Journal Articles

Abstract P1-14-20: Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)

Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Jo Anne Zujewski, Robert Justice, Sibylle Loibl, Lawrence Wickerham, Jan Bogaerts, Jose Baselga, Charles Perou, Gideon Blumenthal, Jens Blohmer, Eleftherios Mamounas, Jonas Bergh, Vladimir Semiglazov, Tatiana Prowell, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter Fasching, Sandra M Swain, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, Wolfgang Eiermann, Gunter von Mincwitz
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P1-14-20.
https://doi.org/10.1158/0008-5472.SABCS12-P1-14-20
Published: 15 December 2012
View article titled, Abstract P1-14-20: Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)
Journal Articles

The Contribution of Medicine to the Primary Treatment of Breast Cancer

Gianni Bonadonna, Pinuccia Valagussa
Journal: Cancer Research
Cancer Res (1988) 48 (9): 2314–2324.
Published: 01 May 1988
View article titled, The Contribution of Medicine to the Primary Treatment of Breast Cancer
Open the PDF for The Contribution of Medicine to the Primary Treatment of Breast Cancer in another window